Vimarsana
Biggest News Aggregation in the World

Dede Sheel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dede Sheel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dede Sheel Today - Breaking & Trending Today

Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and P - Vimarsana News

Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and P

Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipelineScott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the...

Why Aurinia Pharmaceuticals Stock Is In Retreat Today - Vimarsana News

Why Aurinia Pharmaceuticals Stock Is In Retreat Today

Investors are none too pleased with the company's recent slew of hires.

Source: fool.com
Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance - Vimarsana News

Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance

14.07.2022 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced the appointment of three seasoned leaders to the ... Seite 1

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn - Vimarsana News

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn

Sierra Oncology's differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia Momelotinib complements GSK's existing expertise

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, Calif. — Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, granted…